Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome
Vera Bittner, Michael J. Szarek, Philip E. Aylward, Deepak L. Bhatt, Rafael Díaz, Jay M. Edelberg, Zlatko Fras, Shaun G. Goodman, Sigrun Halvorsen, Corinne Hanotin, Robert A. Harrington, J. Wouter Jukema, Virginie Loizeau, Patrick M. Moriarty, Angèle Moryusef, Robert C. Pordy, Matthew T. Roe, Peter Sinnaeve, Sotirios Tsimikas, Robert A. Vogel, Harvey Douglas White, Doron Zahger, Andreas Michael Zeiher, Philippe Gabríel Steg, Gregory G. Schwartz
The abstract is not reproduced here because its license does not permit redistribution. Read it at the original source.
Record
- Archive ID
- doi:10.1016/j.jacc.2019.10.057
- Published
- Jan 1, 2020
- Venue
- Journal of the American College of Cardiology
- DOI
- 10.1016/j.jacc.2019.10.057
- PubMed
- 31948641
- Categories
- Lipoproteins and Cardiovascular Health
- License
- cc-by-nc-nd
- Provenance
- openalex